The Effects of Short-time High-intensity Interval Training on Tissue Glucose and Fat Metabolism in Healthy Subjects and Patients With Type 2 Diabetes (HITPET)

April 28, 2011 updated by: Turku University Hospital
The objectives of this study are to investigate the effects of short-time high-intensity interval training on tissue glucose and fat metabolism in healthy lean subjects and type 2 diabetic patients using modern and noninvasive imaging methods positron emission tomography (PET), magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS).

Study Overview

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Turku, Finland, 20521
        • Recruiting
        • Turku PET Centre
        • Contact:
        • Principal Investigator:
          • Jarna C Hannukainen, PhD
        • Sub-Investigator:
          • Kari K Kalliokoski, PhD
        • Sub-Investigator:
          • Joonas J Eskelinen, BM
        • Sub-Investigator:
          • Anna Savolainen, BM
        • Sub-Investigator:
          • Ilkka Heinonen, PhD
        • Sub-Investigator:
          • Kirsi A Virtanen, PhD
        • Sub-Investigator:
          • Jukka Kemppainen, PhD
        • Sub-Investigator:
          • Juhani Knuuti, Professor
        • Sub-Investigator:
          • Pirjo Nuutila, Professor
        • Sub-Investigator:
          • Jussi Pärkkä, MD
        • Sub-Investigator:
          • Virva Lepomäki, MSc
        • Sub-Investigator:
          • Riitta Parkkola, MD, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 55 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

The healthy patients

  1. Age 40-55
  2. BMI 18.5-30
  3. Fasting plasma glucose less than 6.1 mmol/l
  4. Normal glucose tolerance test (OGTT)

The type 2 diabetic patients:

  1. Age-, sex-, and BMI-matched with the study subjects in the phase 1
  2. In a good treatment balance
  3. Glycated haemoglobin (HbA1c) less than 7.5 mmol/l
  4. Two hours glucose value in oral glucose tolerance test (OGTT) less than 10.0 mmol/l

Exclusion Criteria:

The healthy patients

  1. Blood pressure > 140/90 mmHg
  2. Any chronic disease
  3. Any chronic medical defect or injury which hinder/interfere everyday life
  4. History of anorexia nervosa or bulimia
  5. History of rest or exercise-induced asthma
  6. Previous use of anabolic steroids, additives or any other substrates
  7. Smoking of tobacco, taking of snuffs, or use of narcotics.
  8. Significant use of alcohol
  9. Any other condition that in the opinion of the investigator could create a hazard to the subject safety, endanger the study procedures or interfere with the interpretation of study results
  10. Presence of any ferromagnetic objects that would make MR imaging contraindicated
  11. Current or history of regular and systematic exercise training
  12. VO2max >40 ml/min/kg

The type 2 diabetic patients:

  1. Any other chronic disease than diabetes
  2. Blood pressure > 140/90 mmHg
  3. Any chronic medical defect or injury which hinder/interfere everyday life
  4. History of anorexia nervosa or bulimia
  5. History of rest or exercise-induced asthma
  6. Smoking of tobacco, taking of snuffs, or use of narcotics.
  7. Any other condition that in the opinion of the investigator could create a hazard to the subject safety, endanger the study procedures or interfere with the interpretation of study results
  8. Presence of any ferromagnetic objects that would make MRI imaging contraindicated
  9. Current or history of regular and systematic exercise training
  10. VO2max >40 ml/ min/kg

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: HIT training
Active Comparator: Aerobic exercise training

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

First Submitted

April 28, 2011

First Submitted That Met QC Criteria

April 28, 2011

First Posted (Estimate)

April 29, 2011

Study Record Updates

Last Update Posted (Estimate)

April 29, 2011

Last Update Submitted That Met QC Criteria

April 28, 2011

Last Verified

April 1, 2011

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 2 Diabetes Mellitus

Clinical Trials on HIT exercise intervention

Subscribe